379 related articles for article (PubMed ID: 30452407)
1. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy.
Zhan J; Diao X; Chen Y; Wang W; Ding H
Clin Hemorheol Microcirc; 2019; 72(1):61-73. PubMed ID: 30452407
[TBL] [Abstract][Full Text] [Related]
2. Homogeneity Parameter in Contrast-Enhanced Ultrasound Imaging Improves the Classification of Abnormal Cervical Lymph Node after Thyroidectomy in Patients with Papillary Thyroid Carcinoma.
Zhan J; Diao XH; Chen Y; Wang WP; Ding H
Biomed Res Int; 2019; 2019():9296010. PubMed ID: 31886269
[TBL] [Abstract][Full Text] [Related]
3. Quantitative parameters of contrast-enhanced ultrasound effectively promote the prediction of cervical lymph node metastasis in papillary thyroid carcinoma.
Su B; Li L; Liu Y; Liu H; Zhan J; Chai Q; Fang L; Wang L; Chen L
Drug Discov Ther; 2024 Mar; 18(1):44-53. PubMed ID: 38355122
[TBL] [Abstract][Full Text] [Related]
4. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
Jianming L; Jibin L; Linxue Q
Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
[TBL] [Abstract][Full Text] [Related]
5. Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography.
Xu JM; Xu XH; Xu HX; Zhang YF; Guo LH; Liu LN; Liu C; Bo XW; Qu S; Xing M; Li XL
Eur Radiol; 2016 Aug; 26(8):2611-22. PubMed ID: 26560715
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
[TBL] [Abstract][Full Text] [Related]
7. Score based on contrast-enhanced ultrasound predict central lymph node metastasis in papillary thyroid cancer.
He L; Chen X; Hu J; Meng Y; Zhang Y; Chen W; Fan Y; Li T; Fang J
Front Endocrinol (Lausanne); 2024; 15():1336787. PubMed ID: 38699389
[TBL] [Abstract][Full Text] [Related]
8. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.
Chen S; Niu C; Peng Q; Tang K
Front Endocrinol (Lausanne); 2021; 12():556851. PubMed ID: 33796065
[TBL] [Abstract][Full Text] [Related]
9. Combination of Lymphatic and Intravenous Contrast-Enhanced Ultrasound for Evaluation of Cervical Lymph Node Metastasis from Papillary Thyroid Carcinoma: A Preliminary Study.
Wei Y; Yu MA; Niu Y; Hao Y; Di JX; Zhao ZL; Cao XJ; Peng LL; Li Y
Ultrasound Med Biol; 2021 Feb; 47(2):252-260. PubMed ID: 33158634
[TBL] [Abstract][Full Text] [Related]
10. Value of Qualitative and Quantitative Contrast-Enhanced Ultrasound Analysis in Preoperative Diagnosis of Cervical Lymph Node Metastasis From Papillary Thyroid Carcinoma.
Chen L; Chen L; Liu J; Wang B; Zhang H
J Ultrasound Med; 2020 Jan; 39(1):73-81. PubMed ID: 31222782
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study.
Yang Z; Wang X; Tao T; Zou J; Qiu Z; Wang L; Du H; Chen N; Yin X
BMC Surg; 2023 Oct; 23(1):325. PubMed ID: 37875825
[TBL] [Abstract][Full Text] [Related]
12. Value of clinical features combined with multimodal ultrasound in predicting lymph node metastasis in cervical central area of papillary thyroid carcinoma.
Xue J; Li S; Qu N; Wang G; Chen H; Wu Z; Cao X
J Clin Ultrasound; 2023 Jun; 51(5):908-918. PubMed ID: 37058552
[TBL] [Abstract][Full Text] [Related]
13. Integrating US-guided FNAB, BRAF
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract][Full Text] [Related]
14. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F
Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography.
Xue T; Liu C; Liu JJ; Hao YH; Shi YP; Zhang XX; Zhang YJ; Zhao YF; Liu LP
Front Oncol; 2021; 11():794399. PubMed ID: 35004319
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
[No Abstract] [Full Text] [Related]
17. Effectiveness of Lymphatic Contrast Enhanced Ultrasound in the diagnosis of Cervical Lymph node metastasis from papillary thyroid carcinoma.
Wei Y; Niu Y; Zhao ZL; Cao XJ; Peng LL; Li Y; Yu MA
Sci Rep; 2022 Jan; 12(1):578. PubMed ID: 35022480
[TBL] [Abstract][Full Text] [Related]
18. A Nomogram Based on Clinical and Ultrasound Characteristics to Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Feng JW; Hong LZ; Wang F; Wu WX; Hu J; Liu SY; Jiang Y; Ye J
Front Endocrinol (Lausanne); 2021; 12():666315. PubMed ID: 33995284
[TBL] [Abstract][Full Text] [Related]
19. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
Gao X; Luo W; He L; Cheng J; Yang L
Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
[TBL] [Abstract][Full Text] [Related]
20. Role of Contrast-Enhanced Ultrasound in the Pre-operative Diagnosis of Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma.
Hong YR; Luo ZY; Mo GQ; Wang P; Ye Q; Huang PT
Ultrasound Med Biol; 2017 Nov; 43(11):2567-2575. PubMed ID: 28807450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
